Security key
76243J105
RHYTHM PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (RYTM)
CUSIP: 76243J105
Q1 2023 13F Holders as of 31 Mar 2023
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 69,012,275
- Total 13F shares
- 60,335,883
- Share change
- -2,013,444
- Total reported value
- $1,076,382,910
- Put/Call ratio
- 30%
- Price per share
- $17.84
- Number of holders
- 125
- Value change
- -$49,077,961
- Number of buys
- 74
- Number of sells
- 42
Report period
Q1 2023
Institutions
125
Top holders
10
RYTM full security history
Newer quarter: Q2 2023
Previous quarter: Q4 2022
RHYTHM PHARMACEUTICALS, INC. SEC filings
RHYTHM PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 76243J105
Recent filing periods:
Top shareholders of RYTM - RHYTHM PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
10%
|
6,911,142
|
$201,252,455 | — | 31 Dec 2022 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
9.2%
|
6,354,608
|
$185,046,185 | — | 31 Dec 2022 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
9.1%
|
6,304,482
|
$183,586,516 | — | 31 Dec 2022 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
8%
|
5,516,067
|
$160,627,871 | — | 31 Dec 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
7.5%
|
5,201,792
|
$151,476,183 | — | 31 Dec 2022 | |
| NEA Management Company, LLC |
13F
|
Company |
7.1%
|
4,909,956
|
$142,977,919 | — | 31 Dec 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.4%
|
3,723,714
|
$108,434,552 | — | 31 Dec 2022 | |
| STATE STREET CORP |
13F
|
Company |
4.6%
|
3,180,698
|
$92,621,926 | — | 31 Dec 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.8%
|
2,596,314
|
$75,604,665 | — | 31 Dec 2022 | |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
3.2%
|
2,238,262
|
$65,178,190 | — | 31 Dec 2022 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
2.7%
|
1,894,000
|
$55,153,280 | — | 31 Dec 2022 | |
| Rock Springs Capital Management LP |
13F
|
Company |
2.6%
|
1,760,865
|
$51,276,389 | — | 31 Dec 2022 | |
| Polar Capital Holdings Plc |
13F
|
Company |
1.8%
|
1,250,000
|
$36,400,000 | — | 31 Dec 2022 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1.8%
|
1,240,153
|
$36,113,017 | — | 31 Dec 2022 | |
| FMR LLC |
13F
|
Company |
1.1%
|
773,028
|
$22,510,575 | — | 31 Dec 2022 | |
| Opaleye Management Inc. |
13F
|
Company |
1.1%
|
735,000
|
$21,403,200 | — | 31 Dec 2022 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
1%
|
694,042
|
$20,210,503 | — | 31 Dec 2022 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.67%
|
463,516
|
$13,498,000 | — | 31 Dec 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.66%
|
458,510
|
$13,351,000 | — | 31 Dec 2022 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.52%
|
355,530
|
$10,353,034 | — | 31 Dec 2022 | |
| Samsara BioCapital, LLC |
13F
|
Company |
0.5%
|
345,293
|
$10,054,932 | — | 31 Dec 2022 | |
| Invesco Ltd. |
13F
|
Company |
0.48%
|
334,273
|
$9,734,030 | — | 31 Dec 2022 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.44%
|
306,013
|
$8,911,099 | — | 31 Dec 2022 | |
| CITIGROUP INC |
13F
|
Company |
0.4%
|
275,561
|
$8,024,336 | — | 31 Dec 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.39%
|
266,153
|
$7,750,375 | — | 31 Dec 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.35%
|
243,685
|
$7,096,107 | — | 31 Dec 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.33%
|
229,916
|
$6,695,154 | — | 31 Dec 2022 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.29%
|
199,503
|
$5,809,527 | — | 31 Dec 2022 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.28%
|
194,996
|
$5,678,284 | — | 31 Dec 2022 | |
| UBS Group AG |
13F
|
Company |
0.28%
|
191,265
|
$5,569,636 | — | 31 Dec 2022 | |
| BARCLAYS PLC |
13F
|
Company |
0.26%
|
182,599
|
$5,317,283 | — | 31 Dec 2022 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.26%
|
180,557
|
$5,257,820 | — | 31 Dec 2022 | |
| Altium Capital Management LLC |
13F
|
Company |
0.25%
|
170,000
|
$4,950,400 | — | 31 Dec 2022 | |
| Informed Momentum Co LLC |
13F
|
Company |
0.24%
|
164,695
|
$4,795,918 | — | 31 Dec 2022 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.23%
|
157,862
|
$4,596,941 | — | 31 Dec 2022 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.22%
|
153,202
|
$4,461,242 | — | 31 Dec 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.2%
|
138,101
|
$4,021,501 | — | 31 Dec 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.2%
|
136,991
|
$3,990,000 | — | 31 Dec 2022 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.17%
|
120,689
|
$3,514,464 | — | 31 Dec 2022 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.16%
|
108,562
|
$3,161,325 | — | 31 Dec 2022 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.15%
|
106,916
|
$3,113,394 | — | 31 Dec 2022 | |
| Swiss National Bank |
13F
|
Company |
0.14%
|
97,900
|
$2,850,848 | — | 31 Dec 2022 | |
| Stratos Wealth Partners, LTD. |
13F
|
Company |
0.11%
|
73,320
|
$2,135,078 | — | 31 Dec 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.1%
|
70,698
|
$2,058,726 | — | 31 Dec 2022 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.09%
|
65,138
|
$1,896,819 | — | 31 Dec 2022 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.09%
|
63,595
|
$1,851,886 | — | 31 Dec 2022 | |
| Global IMC LLC |
13F
|
Company |
0.09%
|
62,623
|
$1,823,582 | — | 31 Dec 2022 | |
| Hennion & Walsh Asset Management, Inc. |
13F
|
Company |
0.09%
|
59,298
|
$1,727,000 | — | 31 Dec 2022 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.08%
|
52,884
|
$1,539,982 | — | 31 Dec 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.07%
|
47,491
|
$1,383,000 | — | 31 Dec 2022 |
Institutional Holders of RHYTHM PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (RYTM) as of Q1 2023
As of 31 Mar 2023,
RHYTHM PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (RYTM) was held by
125 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
60,335,883 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, BAKER BROS. ADVISORS LP, RA CAPITAL MANAGEMENT, L.P., GOLDMAN SACHS GROUP INC, FEDERATED HERMES, INC., BlackRock Inc., NEA Management Company, LLC, VANGUARD GROUP INC, STATE STREET CORP, and Frazier Life Sciences Management, L.P..
This page lists
125
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2023 vs Q4 2022 Across Filers
Q4 2022 holders
116
Q1 2023 holders
125
Holder diff
9
| Investor | Q4 2022 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q4 2022 Value $ | Q1 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.